AXIS Capital Reports Strong Q1 2026 Earnings with 45.6% Diluted EPS Growth and New $300M Share Buyback Authorization
Summary
AXIS Capital reported strong Q1 2026 results with a 45.6% increase in diluted EPS and an improved combined ratio, alongside the authorization of a new $300 million share repurchase program.
Key Events
-
Strong Earnings Growth
Net income available to common shareholders surged 32.5% to $247.2 million in Q1 2026, with diluted earnings per share (EPS) increasing by 45.6% to $3.29 compared to Q1 2025.
-
Improved Underwriting Performance
The company's combined ratio improved by 0.4 points to 89.8% in Q1 2026, reflecting better underwriting profitability. Underwriting income rose 14.6% to $187.4 million.
-
Robust Premium Growth
Gross premiums written increased by 10.8% to $3.1 billion, and net premiums earned grew by 10.4% to $1.48 billion in Q1 2026, driven by new business in property, professional lines, and accident and health.
-
New Share Repurchase Program Authorized
The Board of Directors approved a new $300 million share repurchase program on February 26, 2026, supplementing an existing program with $53 million remaining authorization. The company repurchased $60 million under publicly announced programs in Q1 2026.
Analysis
AXIS Capital Holdings Ltd. delivered a robust first quarter, showcasing significant operational and financial improvements. The substantial increase in diluted EPS and net income, coupled with an improved combined ratio, indicates strong underlying business performance. The authorization of a new $300 million share repurchase program signals continued commitment to shareholder returns and capital management. While the top-line net income was previously reported by news outlets, the detailed operational metrics and the new buyback authorization provide material new information, reinforcing a positive outlook for the company's financial health and capital allocation strategy.
At the time of this filing, AXS was trading at $97.96 on NYSE in the Finance sector, with a market capitalization of approximately $7.3B. The 52-week trading range was $88.07 to $110.34. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.